NCT00532909 Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00526110 Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00525915 Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma Status COMPLETED Phase PHASE2
NCT00525785 Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) Status COMPLETED Phase PHASE2
NCT00515216 Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors Status COMPLETED Phase PHASE2
NCT00514020 Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT00513266 Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery Status UNKNOWN Phase PHASE2
NCT00508872 Folfox-B Study for Patients With Colorectal Liver Metastases Status TERMINATED Phase PHASE2
NCT00507585 Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin Status COMPLETED Phase PHASE1
NCT00503997 Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00501410 FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00496704 Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan Status UNKNOWN Phase PHASE1/PHASE2
NCT00492999 Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00491855 Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis Status COMPLETED Phase PHASE1
NCT00483405 Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer Status COMPLETED Phase PHASE2
NCT00482222 Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT00480987 Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS) Status TERMINATED Phase PHASE1/PHASE2